Connection

Giordano Madeddu to HIV Integrase Inhibitors

This is a "connection" page, showing publications Giordano Madeddu has written about HIV Integrase Inhibitors.
Connection Strength

0.036
  1. Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir. AIDS. 2017 01 28; 31(3):455-457.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.